Ftse Mib
34.700,60
1,05%
DAX
18.807,90
0,69%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.994,87
-0,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Innovation Pharmaceuticals Inc (CE) (IPIX) Innovation Pharmaceuticals Inc (CE) (IPIX) Notizie

IPIX

Innovation Pharmaceuticals (CE) (IPIX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:IPIX
DataOraFonteTitoloSimboloCompagnia
01/02/202414:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/11/202322:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/11/202314:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202315:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/05/202314:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/02/202313:31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
04/01/202322:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202222:01Edgar (US Regulatory)Annual Report (10-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202218:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/07/202222:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/11/202115:20InvestorsHub NewsWireIQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should CloseUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/10/202113:00InvestorsHub NewsWireCEO Presenting on the Emerging Growth Conference on October 13 Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
29/09/202114:00InvestorsHub NewsWireCEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202113:24InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% GrowthUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
21/07/202112:47InvestorsHub NewsWireNightfood, Inc. (OTCQB: NGTF) Significant Retail ExpansionUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/06/202113:00InvestorsHub NewsWireThe Emerging Growth Conference is Today.  Register Now.USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/03/202112:37InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company HistoryUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/02/202122:47Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/02/202112:48InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating TargetUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
02/02/202112:52InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New ProductsUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
22/12/202014:05InvestorsHub NewsWireBiotech Companies; Recent Milestones and Potential UpsideUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/12/202012:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/11/202012:48InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) Adds Vaccine Management as part of COVID Compliance FeaturesUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/07/202012:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/07/202023:09Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
16/04/202014:00InvestorsHub NewsWireCannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here!USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
26/12/201923:19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
17/10/201923:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
13/08/201922:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
02/08/201922:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:IPIX

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
MB
Mediobanca Banca di Cred...
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
BIT
G
Generali
BIT
PRY
Prysmian
BIT
BFF
BFF Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network